CG - Leadership updates

Schuck brings deep expertise in scaling data-driven technology platforms and building category-defining companies YipitData, the leading provider of alternative data-driven market intelligence for institutional investors, retailers, consumer brands, and enterprises, today announced that Henry Schuck, Founder and Chief Executive Officer of ZoomInfo (NASDAQ:GTM), has joined its Board of Directors. Schuck brings more than two decades of experience building and scaling data-driven technology platforms. He founded ZoomInfo in 2007 and led its transformation from an early-stage startup into a category-defining B2B intelligence platform, culminating in a successful public listing. Under his le

MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

MCLEAN, Va., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Meghan Harris, President and Chief Operations Officer (COO), to its board of directors. Harris brings over two decades of healthcare quality improvement, strategic operations, and client-focused innovation to the board. As President and COO, she oversees all public and commercial operations, solution development and quality, and contract implementations. "Meghan's appointment to the board reflects the significant impact of her strate

MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced that former Microsoft executive Patty Obermaier has joined the company as Executive Vice President, Chief Growth Officer (CGO). In this role, Obermaier will lead the company's business development, marketing, and product management functions to bring innovative solutions to the healthcare industry's most pressing challenges. A distinguished executive with more than three decades of experience driving innovation, growth, and operational excellence across

Former Morgan Stanley Executives Jeff Levin and Kunal Soni Join as Partners Levin Named Head of Thoma Bravo Credit MIAMI and NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Thoma Bravo, a leading software investment firm, today announced that Jeff Levin and Kunal Soni have joined the firm as partners on the Thoma Bravo Credit platform. Levin has also been named head of the platform. Together with the firm's investors, Thoma Bravo Credit has invested over $25 billion across more than 100 transactions since its inception in 2017. Earlier this year, it successfully closed Thoma Bravo Cre

MCLEAN, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better health outcomes for its clients and the populations they serve, today announced the launch of the Safe AI in Medicaid Alliance (SAMA), a collaborative initiative uniting Medicaid leaders, policy experts, and technology innovators to develop safe and responsible Medicaid-focused frameworks for artificial intelligence (AI) adoption and use. Created with input and participation from the Washington State Health Care Authority (HCA), the Arizona Health Care Cost Containment System (AHCCCS), Amazon Web Services (AWS), McKinsey & Co., Arcadia, an

MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Marnie Keogh has joined the company as Senior Vice President of Marketing. In this role, Keogh will lead the company's integrated marketing strategy, driving initiatives across brand development, digital marketing, thought leadership, and go-to-market campaigns. "Marnie brings a distinguished career in healthcare marketing and communications, with a proven ability to drive brand transformation, operational excellence, and digit

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced a definitive agreement to acquire Calastone, the largest global funds network and leading provider of technology solutions to the wealth and asset management industries, from global investment firm Carlyle. The purchase price is approximately £766 million (approximately US $1.03 billion), subject to certain adjustments. Headquartered in London, Calastone operates the largest global funds network, connecting more than 4,500 of the world's leading financial organizations across 57 markets. The acquisition is expected to close in Q4 2025, subject to regulatory approvals. SS&C expects the acquisition to be accretive within 12 mont

SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost. "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Boar

MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025. In this role, Sager will spearhead enterprise-wide change initiatives to help Acentra Health build upon its strong track record of innovation and execution for its clients. She will provide strategic guidance on process improvements to optimize the development and delivery of the company's products, solutions

London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced the appointment of Robert (Bob) DeBenedetto as Managing Director – Clinical Co-Development. Bob brings to Abingworth over 30 years of experience in the life sciences industry and will be working on Clinical Co-Development deals and execution with new and existing Abingworth portfolio companies. He will be based in Abingworth's Menlo Park, CA, USA office. Prior to joining Abingworth, Bob was the Founder, President and CEO of SFJ Pharmaceuticals Inc. (CA, USA), an Abingworth portfolio company, where he

MCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett Barton as Senior Vice President (SVP) of Client Experience. In this newly created role, Barton will represent the voice of the client across multiple touchpoints to deliver an exceptional experience that supports continued growth for the company and elevates the Acentra Health brand. Barton brings over three decades of experience in healthcare technology and services supporting the public sector and health and human services market. He comes to Acentra Health from Gainwell

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova PartnersFunds will be used to build out Myricx Bio's proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform and advance its pipeline of NMTi-ADCs through clinical proof of concept targeting clinically validated tumour-associated antigensCompany to establish laboratory operations in London's biotech hub, and expand its management and R&D teamsMichael Bauer from Novo Holdings and Lucille Conroy from Abi

MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company's marketing strategy, creating data-driven frameworks to support the company's brand, content, digital, and product marketing programs. She reports to Acentra Health's Chief Growth Officer. "Heather brings a strong portfolio of success in helping companies elevate their brand and drive sustained growth throug

MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Grant Christie as Senior Vice President, Market Strategy and Solutions. A seasoned information technology solutions and services veteran with extensive experience in the public sector and commercial healthcare spaces, Christie will play a pivotal role in aligning Acentra Health's portfolio of products, solutions, and tech-enabled services to meet the needs and demands of the healthcare market and promote continued strong growth for the company.

MCLEAN, Va., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology services and solutions company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Daniel Hallenbeck as Vice President (VP) of Strategy and Strategic Partnerships. A nationally recognized expert in Medicaid Enterprise Systems and a former New York State (NYS) Medicaid Chief Technology Officer (CTO), Hallenbeck will serve as an integral member of the Acentra Health Leadership Team, supporting the Chief Strategy Officer in the development and execution of the company's strategy around value creation, digital health, and mergers and acquisi

NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt

NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Carlyle Credit Income Fund (the "Fund" or "CCIF") (NYSE:CCIF) today is pleased to announce the early completion of the initial transition plan following the appointment of Carlyle Global Credit Investment Management L.L.C., an affiliate of Carlyle (together with their affiliates, "Carlyle"), as CCIF's external investment adviser. The transition plan included the following steps: Carlyle completed the $10 million one-time Payment to the Fund's shareholders of record on July 14, 2023;Carlyle completed the tender offer to purchase $25 mill

Company Changes Investment Mandate to Focus on Investing in CLOsWill Trade Under New Stock Ticker 'CCIF'Carlyle Completes Previously-Announced $10 Million One-Time Payment to Company Shareholders of RecordCarlyle Will Launch $25 Million Tender Offer for Company Shares on July 18, 2023Company Board of Trustees Declares July Dividend of $0.0551NEW YORK, July 17, 2023 /PRNewswire/ -- Vertical Capital Income Fund (NYSE: VCIF) ("VCIF" or the "Company") today announced that it has changed its corporate name from VCIF to Carlyle Credit Income Fund ("CCIF") in connection with the closing of the previously announced transaction with global investment firm, Carlyle (NYSE:CG), and will begin trading un

FGH Parent, L.P. ("Fortitude Re"), today announced the opening of its Tokyo Representative Office and appointment of Hajime Kawafuji as its Chief Representative. Mr. Kawafuji is a leader in the Japanese business community, with a broad range of investing and advisory experience across several industries. He joins Fortitude Re from global investment firm Carlyle (NASDAQ:CG), where he was a senior member of the Japan buyout advisory team. Prior to Carlyle, Mr. Kawafuji spent more than a decade at Nomura in its Investment Banking division. Mr. Kawafuji will partner with Leonard Lin, Head of Asia at Fortitude Re, to deliver the continued high-quality execution and tailored solutions that clie

New board members brings deep understanding of private markets and technology for institutional investors Chronograph, provider of the world's leading portfolio monitoring solutions for private equity, today announced the appointment of Ben Harrison, President of Financial Services at Intapp (NASDAQ:INTA), and Julian Rampelmann, Managing Director at Carlyle Group (NASDAQ:CG), to its Board of Directors. Harrison has deep experience in private markets technology, serving as Co-Founder of DealCloud and President of Financial Services at Intapp since 2018. DealCloud is the leading CRM, deal sourcing, and fund management platform for capital markets. As part of Intapp, DealCloud empowers pro

NEW YORK and WASHINGTON, April 26, 2023 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) today announced the appointment of Sharda Cherwoo, retired Ernst & Young LLP ("EY") senior partner, to serve as an independent director of its Board of Directors and a member of the Audit Committee of the Board, effective June 1, 2023. With this appointment, Carlyle's Board of Directors will comprise 13 members. Ms. Cherwoo spent her entire, nearly 40-year career at Ernst & Young (EY), with a specialized industry focus on private equity, financial services, health care, and emerging disruptive technologies, across diverse industries. Most recently, she served as EY's Americas Intelligent

            Gordulic is Seasoned and Long-Serving Finance Team Member Who Played Critical Role in Carlyle's 2022 Acquisition of the Company HONOLULU and CEDAR RAPIDS, Iowa, Jan. 17, 2023 /PRNewswire/ -- Involta, an industry-leading hybrid IT, cloud computing, and data center services company, announces the promotion of Carl Gordulic to Chief Financial Officer. Gordulic played an instrumental role in facilitating the acquisition of Involta by global investment firm Carlyle (NASDAQ:CG). The deal, which closed in 2022, has spurred expansion, investment and additions to Involta's leadership team this past year. CG). The deal, w

LONDON, Dec. 13, 2022 /PRNewswire/ -- Abingworth, a leading international life sciences investment group, announces the appointment of Joy Ghosh, PhD as Managing Director. Joy will be based at the firm's Boston, MA office and will work with the transatlantic team to identify new investment opportunities and support existing investments in innovative private and public companies, including those focused on clinical co-development. Joy brings to Abingworth over 15 years' experience in life science investing and portfolio company management and in corporate strategy and drug development. He joins from Eventide Asset Management where he was Portfolio Manager responsible for a portfolio of innova

STOCKHOLM, SE / ACCESSWIRE / September 28, 2022 / Hilbert Group (STO:HILB-B) (FRA:999) Hilbert Group AB, the Nasdaq First North listed investment firm (ticker: Hilb B) focusing on digital assets and blockchain technology, appoints Bruce Terry as senior advisor.Bruce brings four decades of hedge fund and private equity experience to the team, where he will advise and support the development of investment solutions and fundraising of capital. Previously, Bruce was the Chief Executive Officer of Brevan Howard US. Prior to his current role, he was a Managing Director at The Carlyle Group (NASDAQ:CG).Niclas Sandström, CEO of Hilbert Group, said: "We are delighted to have a hedge fund industry lea

Gary Wojtaszek Will Help Guide Involta's Growth as Company Leverages Carlyle's Recent Capital Investment CEDAR RAPIDS, Iowa, Aug. 16, 2022 /PRNewswire/ -- Involta, an industry-leading hybrid IT, cloud computing, and data center services company, welcomes Gary Wojtaszek to its Board of Directors. He joins Involta President and CEO James (Jim) Buie as the most recent board member following the company's acquisition by global investment firm Carlyle (NASDAQ:CG). Both will serve under the leadership of Board Chairman Ed Vilandrie, an Operating Executive for The Carlyle Group, and Involta Founder and former CEO Bruce Lehrman, Board Vice Chairman.

LONDON, March 24, 2021 /PRNewswire/ -- Fimatix has announced the appointment of Cristóbal Conde as Non-Executive Chairman effective from 23 March 2021. Formerly Chairman of Calastone, the major global funds network recently sold to The Carlyle Group (NASDAQ: CG), Conde brings a wealth of business, fintech and investment experience. He will work closely with the senior management team as Fimatix continues its growth and M&A drive, identifying opportunities to acquire other fintech and govtech firms. Cristóbal Conde, newly appointed Chairman of Fimatix Conde has a strong track record of accelerating the growth of fintech companies. In 1983 Conde co-founded a financial tech

ARLINGTON, Va., March 09, 2021 (GLOBE NEWSWIRE) -- Two Six Technologies, a high-growth, technology-focused provider to the U.S. Intelligence Community, Department of Defense, and other U.S. national security customers, announced today that it has appointed four individuals to its Board of Directors, including two proven government leaders and two highly accomplished executives focused on technology and innovation. With deep experience across government, intelligence, cybersecurity and related business sectors, the addition of these directors bolsters Two Six Technologies’ ability to develop technology solutions to solve the most complex and important missions of its national security custo